(Q33537690)

27 July 2017

1 reference

title

The management of PSA failure after radical radiotherapy for localized prostate cancer (English)

1 reference

adaptive radiation therapy

27 July 2017

main subject

0 references

1 reference

Parker CC

1

1 reference

27 July 2017

Dearnaley DP

series ordinal

2

1 reference

27 July 2017

publication date

1 November 1998

1 reference

Radiotherapy and Oncology

27 July 2017

published in

1 reference

27 July 2017

volume

49

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

103-110

1 reference

Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Radical prostatectomy after radiotherapy for prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Percutaneous cryoablation of the prostate: preliminary results after 95 procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Radiotherapy for localized prostate carcinoma. The correlation of pretreatment prostate specific antigen and nadir prostate specific antigen with outcome as assessed by systematic biopsy and serum prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Radiotherapy for prostate cancer: the changing scene

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Antiandrogen monotherapy in the management of advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Radical prostatectomy after definitive radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Use of percutaneous transperineal 198Au seeds to treat recurrent prostate adenocarcinoma after failure of definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Ablation of tissue volumes using high intensity focused ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Percutaneous, transperineal cryosurgery of the prostate as salvage therapy for post radiation recurrence of adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

The role of radical surgery in the management of radiation recurrent and large volume prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Salvage Radical Prostatectomy for Radiorecurrent Adenocarcinoma of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

The efficacy and complications of salvage cryotherapy of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Salvage surgery for radiation failure in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Salvage radical prostatectomy after failure of curative radiotherapy for adenocarcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Salvage radical prostatectomy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

125iodine reimplantation for locally progressive prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

The fall and rise of prostate-specific antigen. Kinetics of serum prostate-specific antigen levels after radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2898%2900107-8

7 January 2021

10.1016/S0167-8140(98)00107-8

Identifiers

DOI

1 reference

27 July 2017

1 reference